Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dermata Therapeutics Inc

5.50
-0.3300-5.66%
Volume:36.82K
Turnover:206.10K
Market Cap:3.75M
PE:-0.13
High:5.84
Open:5.74
Low:5.34
Close:5.83
52wk High:24.90
52wk Low:5.09
Shares:681.56K
Float Shares:459.20K
Volume Ratio:1.39
T/O Rate:8.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-42.3158
EPS(LYR):-80.3223
ROE:-231.27%
ROA:-110.91%
PB:0.67
PE(LYR):-0.07

Loading ...

Mar 21, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2024

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Correspondence

Form CORRESP - Correspondence
Nov 17, 2023

Major Issues Report

Form 8-K - Current report
Nov 16, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 14, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Correspondence

Form CORRESP - Correspondence
Jul 08, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 02, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership